A prospective, multicenter phase 2 trial evaluated the safety of neoadjuvant radiation plus immunotherapy before radical cystectomy for bladder cancer.

Prophylactic tranexamic acid showed no reduction in blood transfusion rates in open radical cystectomy patients. The trial found no significant differences in secondary outcomes, including estimated ...

In the past decade there has been a rapid expansion of the use of robotic assistance during surgery that involves minimally invasive approaches. In the United Kingdom, robot-assisted radical ...

Perioperative management for muscle invasive bladder cancer (MIBC) includes neoadjuvant cisplatin-based chemotherapy (NAC) followed by radical cystectomy and risk-adapted adjuvant immunotherapy. More ...

Phase II study tested combination of sacituzumab govitecan plus pembrolizumab ...

A 30-day course of prophylactic antibiotics following robot-assisted radical cystectomy significantly reduces the incidence of urinary tract infections (UTIs) and related complications, researchers ...

The following represents disclosure information provided by the author of this manuscript. All relationships are considered compensated unless otherwise noted. Relationships are self-held unless noted ...

Identifying specific patient risks can help reduce post-radial cystectomy infections, operative time and blood transfusions, according to research presented at the American Urological Association ...

The authors have no relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in ...

The incidence of urinary tract infections after radical cystectomy differs according to how much time elapsed from discharge, with patients who experience UTIs 31-90 days post-discharge at higher ...